Neomycin review scope document

The APVMA has commenced a reconsideration (hereafter referred to as review), of the registrations of products, which are oral, intramammary and injectable preparations of neomycin and their approved associated labels. This document defines the scope of the review. 

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.